Sclerostin antibody improves alveolar bone quality in the Hyp mouse model of X-Linked Hypophosphatemia (XLH)

Mostrar otras versiones (1)

X-linked hypophosphatemia (XLH) is a rare disease of elevated fibroblast growth factor 23 (FGF23) production that leads to hypophosphatemia and poor mineralization of bone and teeth. The clinical manifestations of XLH include a high prevalence of dental abscesses, likely driven by poorly formed stru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ross, Ryan, Carpenter, Kelsey, Alkhatib, Delia, Dulion, Bryan, Guirado, Elizabeth, Patel, Shreya, Chen, Yinghua, George, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120757/
https://www.ncbi.nlm.nih.gov/pubmed/37090634
http://dx.doi.org/10.21203/rs.3.rs-2762671/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120757/
https://www.ncbi.nlm.nih.gov/pubmed/37090634
http://dx.doi.org/10.21203/rs.3.rs-2762671/v1

Ejemplares similares